Guntur Gunawan

Quality Control Analyst at PT. CKD OTTO PHARMACEUTICALS
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
ID
Languages
  • English Professional working proficiency
  • Indonesian Native or bilingual proficiency
  • Minangkabau Native or bilingual proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Credentials

  • Certificate of Competence in Volumetric Analysis
    Badan Nasional Sertifikasi Profesi
    Jan, 2018
    - Nov, 2024
  • Certificate of Competence in Clinical Chemistry
    Badan Nasional Sertifikasi Profesi
    Jan, 2018
    - Nov, 2024
  • Certificate of Competence in Electrochemical Analysis
    Badan Nasional Sertifikasi Profesi
    Jan, 2018
    - Nov, 2024
  • Certificate of Competence in Gravimetric Analysis
    Badan Nasional Sertifikasi Profesi
    Jan, 2018
    - Nov, 2024
  • Certificate of Competence in UV-Vis Spectrophotometer
    Badan Nasional Sertifikasi Profesi
    Jan, 2018
    - Nov, 2024
  • Certificate of Competence of Atomic Absorption Spectrophotometer
    Badan Nasional Sertifikasi Profesi
    Jan, 2018
    - Nov, 2024

Experience

  • PT. CKD OTTO PHARMACEUTICALS
    • Indonesia
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Quality Control Analyst
      • Dec 2020 - Present

  • Mahakam Beta Farma
    • Indonesia
    • Pharmaceutical Manufacturing
    • 100 - 200 Employee
    • Research And Development Analyst
      • Mar 2019 - Dec 2020

  • PT Dankos Farma
    • Indonesia
    • Pharmaceutical Manufacturing
    • 400 - 500 Employee
    • Quality Control Analyst
      • Jun 2018 - Mar 2019

Education

  • Universitas Pelita Bangsa (UPB)
    Bachelor of Engineering - BE, Environmental/Environmental Health Engineering
    2020 - 2024
  • SMK SMAK Padang
    Chemical Engineering
    2014 - 2018

Community

You need to have a working account to view this content. Click here to join now